| Dr Debra Lea Montgomery, DO, MPH | |
|
1500 W I 240 Service Rd, Oklahoma City, OK 73159-8209 | |
| (405) 632-1002 | |
| Not Available |
| Full Name | Dr Debra Lea Montgomery |
|---|---|
| Gender | Female |
| Speciality | Preventive Medicine - Occupational Medicine |
| Location | 1500 W I 240 Service Rd, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891825337 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083X0100X | Preventive Medicine - Occupational Medicine | 2394 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Debra Lea Montgomery, DO, MPH 1500 W I 240 Service Rd Ste A14, Oklahoma City, OK 73159-8203 Ph: (405) 632-1002 | Dr Debra Lea Montgomery, DO, MPH 1500 W I 240 Service Rd, Oklahoma City, OK 73159-8209 Ph: (405) 632-1002 |
News Archive
A recent study by the University of Eastern Finland shows that scaling maximal oxygen uptake and maximal workload by body weight confounds measures of cardiorespiratory fitness. It has been a common practice in exercise testing to scale the results by body weight and, according to researchers, this practice should be abandoned. More reliable data on cardiorespiratory fitness can be observed by using lean mass proportional measures.
Following a recall by Unilever The Stop & Shop Supermarket Company removed from sale Shedd's Country Crock ® Side Dishes DELUXE Cheddar Broccoli Rice and Shedd's Country Crock ® Side Dishes DELUXE Four Cheese Pasta due to an undeclared sulfite allergen.
The use of adjuvant chemotherapy in early-stage non-small cell lung cancer (NSCLC) patients improves overall survival (OS) and 5-year OS in patients with tumor sizes ranging from 3 - 7 cm.
Egalet Corporation today announced positive results from a Category 3 intranasal human abuse liability (HAL) study of Egalet-001, an abuse-deterrent, extended-release, oral morphine formulation in late-stage clinical development for the management of pain severe enough to require daily, around-the-clock opioid treatment and for which alternative treatments are inadequate.
Gene therapy using an optimized adeno-associated virus to deliver the human factor VIII gene to cynomolgus macaques showed a substantial increase in hFVIII expression and no detectable antibody response for 30 weeks in some animals.
› Verified 8 days ago
Peyton Edward Osborne, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 5909 N Barnes Ave, 301 N. Harvey, Oklahoma City, OK 73112 Phone: 405-553-3367 | |
Dr. Karen A Heupel, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: Federal Aviation Administration, Aam-700 Bldg 13, Oklahoma City, OK 73169 Phone: 405-954-1000 | |
Dr. Stephen L Carpenter, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 6700 S Macarthur Blvd, Cami Building Room B-13, Oklahoma City, OK 73169 Phone: 405-954-3341 Fax: 405-954-3345 | |
Dr. Randel Dean Estep, DO Preventive Medicine Medicare: Medicare Enrolled Practice Location: 4901 W Reno Ave, Ste 500, Oklahoma City, OK 73127 Phone: 405-230-9250 Fax: 405-943-0742 | |
William Dunlop Jones Iv, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 707 Nw 13th St, Oklahoma City, OK 73103 Phone: 405-521-8604 Fax: 405-521-8605 | |
Dr. Dale Gene Claflin, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 921 Ne 23rd St, Oklahoma City, OK 73105 Phone: 405-425-4486 Fax: 405-419-4250 | |
Dr. Myron Mills, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 238 S Quadrum Dr, Oklahoma City, OK 73108 Phone: 405-416-4246 Fax: 405-949-9352 |